Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Medicis Sues Aurobindo Over U.S. Patents for Solodyn Acne Drug

Dec. 3 (Bloomberg) -- Medicis Pharmaceutical Corp. sued Indian rival Aurobindo Pharma Ltd. in federal court in Delaware, seeking to block a generic form of the acne medicine Solodyn and alleging infringement of two U.S. patents.

Link to Company News:{ARBP IN <Equity> CN <GO>} Link to Company News:{MRX US <Equity> CN <GO>}

To contact the reporter on this story: Phil Milford in Wilmington at

To contact the editor responsible for this story: Fred Strasser at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.